Stock data
Oramed Pharmaceuticals Inc. (ORMP)
Oramed Pharmaceuticals Inc. (ORMP) reported revenue of US$2.00M and net income of US$64.05M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$2.00M | US$0.01M | -US$15.09M | US$64.05M | — |
| 2024 | — | — | -US$12.78M | -US$19.06M | — |
| 2023 | US$1.34M | — | -US$15.77M | US$5.09M | — |
| 2022 | US$2.70M | — | -US$40.60M | -US$36.56M | — |
| 2021 | US$2.70M | — | -US$24.22M | -US$22.99M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | US$78.16M | — |
| 2026-03-31 | — | US$38.31M | — |
| 2025-12-31 | — | US$10.01M | — |
| 2025-09-30 | — | US$48.40M | — |
| 2025-06-30 | — | US$13.29M | — |
| 2025-03-31 | US$2.00M | -US$7.64M | — |
| 2024-12-31 | — | -US$10.19M | — |
| 2024-09-30 | — | -US$19.62M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.